| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | Chief Medical Officer | Common Stock | 1.1K | $3.64K | $3.31 | Jun 28, 2021 | Direct |
| Astria Therapeutics, Inc. | Chief Medical Officer | Common Stock | 0 | $0 | $13.59 | Apr 1, 2024 | Direct |
| Astria Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 263K | Mar 21, 2025 | Direct | ||
| Fulcrum Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 59.7K | Jan 19, 2022 | Direct | ||
| Fulcrum Therapeutics, Inc. | Chief Medical Officer | No securities are beneficially owned | 0 | May 10, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATXS | Astria Therapeutics, Inc. | Mar 21, 2025 | 1 | $0 | 4 | Mar 25, 2025 | Chief Medical Officer |
| ATXS | Astria Therapeutics, Inc. | Apr 1, 2024 | 3 | -$97.2K | 4 | Apr 3, 2024 | Chief Medical Officer |
| ATXS | Astria Therapeutics, Inc. | Feb 8, 2024 | 1 | $0 | 4 | Feb 12, 2024 | Chief Medical Officer |
| ATXS | Astria Therapeutics, Inc. | Jan 26, 2024 | 6 | -$72.7K | 4 | Jan 30, 2024 | Chief Medical Officer |
| ATXS | Astria Therapeutics, Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 6, 2023 | Chief Medical Officer |
| ATXS | Astria Therapeutics, Inc. | Aug 1, 2022 | 1 | $0 | 4 | Aug 2, 2022 | Chief Medical Officer |
| ATXS | Astria Therapeutics, Inc. | Jul 14, 2022 | 0 | $0 | 3 | Jul 15, 2022 | Chief Medical Officer |
| FULC | Fulcrum Therapeutics, Inc. | Jan 19, 2022 | 1 | $0 | 4 | Jan 21, 2022 | Chief Medical Officer |
| FULC | Fulcrum Therapeutics, Inc. | Jun 28, 2021 | 1 | $10.1K | 4 | Jun 29, 2021 | Chief Medical Officer |
| FULC | Fulcrum Therapeutics, Inc. | May 10, 2021 | 1 | $0 | 4 | May 12, 2021 | Chief Medical Officer |
| FULC | Fulcrum Therapeutics, Inc. | May 10, 2021 | 0 | $0 | 3 | May 12, 2021 | Chief Medical Officer |